Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report

被引：10
|
作者：
He, Xi [1 ]
Jiao, Xiao-Dong [1 ]
Liu, Ke [1 ]
Qin, Bao-Dong [1 ]
Wu, Ying [1 ]
Ling, Yan [1 ]
Liu, Jun [1 ]
Xu, A-Qiao [2 ]
Song, Kun [3 ]
Zang, Yuan-Sheng [1 ]
机构：
[1] Naval Med Univ, Changzheng Hosp, Dept Med Oncol, Hetian Rd 64, Shanghai 200070, Peoples R China
[2] Shaoxing Cent Hosp, Shaoxing, Zhejiang, Peoples R China
[3] Shaoxing Peoples Hosp, Shaoxing, Zhejiang, Peoples R China
来源：
JCO PRECISION ONCOLOGY | 2021年 / 5卷
关键词：
CANCER; ADENOCARCINOMA; CHEMOTHERAPY; FUSIONS; KINASE;
D O I：
10.1200/PO.20.00534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：771 / 778
页数：8
相关论文
共 50 条
  • [1] ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review
    Kathuria-Prakash, Nikhita
    Lopez, Lidia P.
    Raman, Steven
    Ye, Huihui
    Anaokar, Jordan
    Sisk, Anthony
    Pantuck, Allan J.
    Drakaki, Alexandra
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [2] ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review
    Kathuria-Prakash, Nikhita
    Lopez, Lidia P.
    Raman, Steven
    Ye, Huihui
    Anaokar, Jordan
    Sisk, Anthony
    Pantuck, Allan J.
    Drakaki, Alexandra
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [3] Dramatic response to crizotinib in a breast cancer patient with ALK gene rearrangement
    Kus, Tulay
    Aktas, Gokmen
    Oktay, Cemil
    Puyan, Fulya Oz
    Tastekin, Ebru
    [J]. ANTI-CANCER DRUGS, 2022, 33 (04) : 400 - 405
  • [4] A novel GHR-ALK fusion gene in a patient with metastatic lung adenocarcinoma and its response to crizotinib: a case report
    Pan, Xue
    Zhong, Anyuan
    Xing, Yufei
    Li, Xi
    Du, Haiwei
    Shi, Minhua
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (09)
  • [5] ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report
    Gonzalez-Mosquera, Luis F.
    Abu Rous, Fawzi
    Rogers, Alexandra
    Smith, Nicolina
    Goyert, Gregory
    Gadgeel, Shirish
    [J]. CLINICAL LUNG CANCER, 2024, 25 (02) : e77 - e80
  • [6] EML4–ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
    Thomas Huang
    Brigitte J. Engelmann
    Rachael M. Morgan
    Kimberly J. Absher
    Jill M. Kolesar
    John L. Villano
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 965 - 968
  • [7] EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
    Huang, Thomas
    Engelmann, Brigitte J.
    Morgan, Rachael M.
    Absher, Kimberly J.
    Kolesar, Jill M.
    Villano, John L.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 965 - 968
  • [8] Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
    Flávia Amaral Duarte
    Leonardo Brand Rodrigues
    Flávia Rocha Paes
    Paulo Henrique Costa Diniz
    Helena Flávia Cuba de Almada Lima
    [J]. BMC Pulmonary Medicine, 21
  • [9] Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
    Duarte, Flavia Amaral
    Rodrigues, Leonardo Brand
    Paes, Flavia Rocha
    Costa Diniz, Paulo Henrique
    Cuba de Almada Lima, Helena Flavia
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [10] Colorectal Cancer with EML4-ALK Fusion Gene Response to Alectinib: A Case Report and Review of the Literature
    Hsiao, Sheng-Yen
    He, Hong-Lin
    Weng, Teng-Song
    Lin, Cheng-Yao
    Chao, Chien-Ming
    Huang, Wen-Tsung
    Tsao, Chao-Jung
    [J]. CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 232 - 238
12345